Agios Pharmaceuticals (AGIO) News Today $38.18 -1.09 (-2.78%) Closing price 04:00 PM EasternExtended Trading$38.89 +0.71 (+1.86%) As of 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Capital Fund Management S.A. Buys Shares of 72,302 Agios Pharmaceuticals, Inc. $AGIOAugust 27 at 4:49 AM | marketbeat.comCharles Schwab Investment Management Inc. Trims Stock Holdings in Agios Pharmaceuticals, Inc. $AGIOAugust 26 at 3:05 AM | marketbeat.comAgios Pharmaceuticals, Inc. $AGIO Holdings Raised by Algert Global LLCAugust 24, 2025 | marketbeat.comVanguard Group Inc. Has $164.22 Million Position in Agios Pharmaceuticals, Inc. $AGIOAugust 23, 2025 | marketbeat.comErste Asset Management GmbH Raises Position in Agios Pharmaceuticals, Inc. $AGIOAugust 22, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Rating of "Moderate Buy" by BrokeragesAugust 19, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Moderate Buy" from BrokeragesAugust 18, 2025 | americanbankingnews.comE Fund Management Co. Ltd. Takes $256,000 Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 17, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) CEO Brian Goff Sells 11,085 SharesAugust 14, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Buys 260,845 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 12, 2025 | marketbeat.comAgios Pharma (AGIO) Gets a Buy from ScotiabankAugust 12, 2025 | theglobeandmail.comAgios Pharmaceuticals’ Earnings Call Highlights Growth and ChallengesAugust 12, 2025 | theglobeandmail.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Headlands Technologies LLCAugust 11, 2025 | marketbeat.comCommerce Bank Buys New Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 9, 2025 | marketbeat.comAgios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down - Should You Sell?August 5, 2025 | marketbeat.comAgios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA ConcernsAugust 5, 2025 | msn.comSFDA approves Agios Pharma’s Pyrukynd for thalassemiaAugust 5, 2025 | finance.yahoo.comAgios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi ArabiaAugust 4, 2025 | globenewswire.comAgios falls as Leerink cites deaths linked to lead asset PyrukyndAugust 4, 2025 | msn.comAgios shares drop after report notes deaths of Pyrukynd patientsAugust 4, 2025 | finance.yahoo.comAgios Shares Fall 15% After Report of Deaths Among Pyrukynd PatientsAugust 4, 2025 | msn.comBIT Capital GmbH Purchases New Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 4, 2025 | marketbeat.comTD Asset Management Inc Acquires 12,400 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 3, 2025 | marketbeat.comAgios Pharmaceuticals (NASDAQ:AGIO) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPSAugust 2, 2025 | marketbeat.comAgios Pharmaceuticals Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsAugust 2, 2025 | finance.yahoo.comUniversal Beteiligungs und Servicegesellschaft mbH Takes $1.60 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 2, 2025 | marketbeat.comAgios (AGIO) Q2 Revenue Jumps 45%August 1, 2025 | fool.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | msn.comGSA Capital Partners LLP Trims Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)August 1, 2025 | marketbeat.comAgios Pharmaceuticals, Inc.: Agios Reports Second Quarter 2025 Financial Results and Provides Business UpdateJuly 31, 2025 | finanznachrichten.deAgios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call TranscriptJuly 31, 2025 | seekingalpha.comAgios Reports Second Quarter 2025 Financial Results and Provides Business UpdateJuly 31, 2025 | globenewswire.comAllianz Asset Management GmbH Sells 26,347 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)July 30, 2025 | marketbeat.comScotiabank Issues Pessimistic Forecast for Agios Pharmaceuticals (NASDAQ:AGIO) Stock PriceJuly 29, 2025 | marketbeat.comAgios Pharmaceuticals (AGIO) Projected to Post Earnings on ThursdayJuly 24, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of "Moderate Buy" by BrokeragesJuly 24, 2025 | marketbeat.comBank of America Has Lowered Expectations for Agios Pharmaceuticals (NASDAQ:AGIO) Stock PriceJuly 22, 2025 | marketbeat.comGW&K Investment Management LLC Purchases 134,063 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)July 22, 2025 | marketbeat.comDavid Scadden Sells 1,400 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) StockJuly 16, 2025 | insidertrades.comInsider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Director Sells 1,400 Shares of StockJuly 15, 2025 | marketbeat.comCenterBook Partners LP Sells 197,090 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)July 15, 2025 | marketbeat.comAgios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ETJuly 14, 2025 | globenewswire.comFY2025 Earnings Estimate for AGIO Issued By Zacks ResearchJuly 14, 2025 | marketbeat.comAgios pharma chief medical officer Gheuens sells $452,601 in stockJuly 13, 2025 | investing.comInsider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells 11,914 Shares of StockJuly 11, 2025 | marketbeat.comAgios Pharmaceuticals Shows Improved Relative Price Performance; Still Shy Of BenchmarkJuly 10, 2025 | msn.comAgios Pharmaceuticals (AGIO) Moves 7.7% Higher: Will This Strength Last?July 10, 2025 | msn.comAgios Pharmaceuticals Inc. (AGIO) Stock Price Today - WSJJuly 8, 2025 | wsj.comAgios Appoints Dr. Jay Backstrom to Board of DirectorsJuly 8, 2025 | globenewswire.comInsider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells 4,091 Shares of StockJuly 4, 2025 | insidertrades.com Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AGIO Media Mentions By Week AGIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGIO News Sentiment▼1.680.99▲Average Medical News Sentiment AGIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGIO Articles This Week▼66▲AGIO Articles Average Week Get the Latest News and Ratings for AGIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Elanco Animal Health News Verona Pharma PLC American Depositary Share News Roivant Sciences News Grifols News Revolution Medicines News Rhythm Pharmaceuticals News Legend Biotech News Avidity Biosciences News Axsome Therapeutics News Abivax News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGIO) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access